Neutron capture therapy (NCT) is a type of radiotherapy for treating locally invasive malignant tumors such as primary brain tumors, recurrent cancers of the head and neck region, and cutaneous and extracutaneous melanomas. It is a two-step process: first, the patient is injected with a tumor-localizing drug containing the stable isotope boron-10 (10B), which has a high propensity to capture low energy "thermal" neutrons. The neutron cross section of 10B (3,837 barns) is 1,000 times more than that of other elements, such as nitrogen, hydrogen, or oxygen, that occur in tissue. In the second step, the patient is radiated with epithermal neutrons, the sources of which in the past have been nuclear reactors and now are accelerators that produce higher energy epithermal neutrons.
The global market for Neutron Capture Therapy of Cancer is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Neutron Capture Therapy of Cancer market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Neutron Capture Therapy of Cancer market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Neutron Capture Therapy of Cancer market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Neutron Capture Therapy of Cancer market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Neutron Capture Therapy of Cancer players cover TAE Life Sciences, RaySearch, Neutron Therapeutics, International Particle Therapy and Southern TOHOKU Hospital Group and etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Neutron Capture Therapy of Cancer market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Neutron Capture Therapy of Cancer market, with both quantitative and qualitative data, to help readers understand how the Neutron Capture Therapy of Cancer market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Neutron Capture Therapy of Cancer market and forecasts the market size by Type (Thermal Beam and Epithermal Beam,), by Application (Brain Tumor, Extracranial Tumor and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Thermal Beam
Epithermal Beam
Segmentation by application
Brain Tumor
Extracranial Tumor
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
TAE Life Sciences
RaySearch
Neutron Therapeutics
International Particle Therapy
Southern TOHOKU Hospital Group
Neuboron Medtech
Chapter Introduction
Chapter 1: Scope of Neutron Capture Therapy of Cancer, Research Methodology, etc.
Chapter 2: Executive Summary, global Neutron Capture Therapy of Cancer market size and CAGR, Neutron Capture Therapy of Cancer market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Neutron Capture Therapy of Cancer revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Neutron Capture Therapy of Cancer revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Neutron Capture Therapy of Cancer market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including TAE Life Sciences, RaySearch, Neutron Therapeutics, International Particle Therapy, Southern TOHOKU Hospital Group and Neuboron Medtech, etc.
Chapter 14: Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Neutron Capture Therapy of Cancer. Industry analysis & Market Report on Neutron Capture Therapy of Cancer is a syndicated market report, published as Global Neutron Capture Therapy of Cancer Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Neutron Capture Therapy of Cancer market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.